RE: RNS23 Nov 2016 10:45
It's just an analyst visit. They take place regularly but it is a chance to market the company.
The presentation associated with the visit is significant. I haven't had a chance to look at it all (it is pretty comprehensive) but a couple of things stand out on an initial scan that haven't to my knowledge been announced/ stated before, namely:
1. There is an initial cut of a revised Base Case Mine Plan that is due in Q1 2017 (see slide 17). Very significant this and shows a 7 year mine life based on underground operations. I find it hard to believe that they could come out with this unless they were very confident (i.e. 100% sure) that this was the case. Real egg on their faces if they do not deliver at least this base case now. Which suggests that there may even be potential upsides but I would be happy with the 7 year mine life. This is not currently reflected in the price in my opinion.
2. Slide 8 states something I have not seen stated before and actually goes against what I believed was likely to happen, namely that there will be a "Reducing capital demand going forward". This was always possible with the current significant capital expenditure items coming to an end. However, my expectation was that they would want to push forward with further developments, particularly at Singida but also at the satellite deposits, as soon as possible which would suggest continued capital outlay. I still expect this but, given the timescale of the pilot at Singida, I suppose that there will likely be a 6-12 month lull in capital expenditure (not that it will disappear entirely). Such a period will materially and positively impact the debt position given the cash generation currently being achieved.
Given that the Shanta share price has always been hampered, so it is said, by the relatively short mine life and the debt position, these two items should materially affect the valuation of the company. If the gold price remains supportive, I suspect that we will find out over the coming months.